Literature DB >> 20683685

Late-onset differentiation syndrome in a child with acute promyelocytic leukemia.

Hisao Yoshida, Risa Matsumura, Emiko Sato, Yoshiko Hashii, Hideaki Ohta, Keiichi Ozono.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20683685     DOI： 10.1007/s12185-010-0647-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

1.  GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children.

Authors:  Anna Maria Testi; Andrea Biondi; Francesco Lo Coco; Maria Luisa Moleti; Fiorina Giona; Marco Vignetti; Giuseppe Menna; Franco Locatelli; Andrea Pession; Elena Barisone; Giulio De Rossi; Daniela Diverio; Concetta Micalizzi; Maurizio Aricò; Giuseppe Basso; Robert Foa; Franco Mandelli
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

2.  Enhanced migration of the acute promyelocytic leukemia cell line NB4 under in vitro conditions during short-term all-trans-retinoic acid treatment.

Authors:  C Zang; H Liu; C Ries; M G Ismair; P E Petrides
Journal:  J Cancer Res Clin Oncol       Date:  2000-01       Impact factor: 4.553

3.  Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells.

Authors:  Misako Shibakura; Kenji Niiya; Masami Niiya; Noboru Asaumi; Chikamasa Yoshida; Yasunari Nakata; Mitsune Tanimoto
Journal:  Leuk Res       Date:  2005-02-26       Impact factor: 3.156

4.  Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.

Authors:  S de Botton; V Coiteux; S Chevret; C Rayon; E Vilmer; M Sanz; J de La Serna; N Philippe; A Baruchel; G Leverger; A Robert; J San Miguel; E Conde; J J Sotto; D Bordessoule; N Fegueux; M Fey; A Parry; C Chomienne; L Degos; P Fenaux
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

Review 5.  Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.

Authors:  L Vahdat; P Maslak; W H Miller; A Eardley; G Heller; D A Scheinberg; R P Warrell
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

6.  All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia.

Authors:  J Seale; L Delva; P Renesto; N Balitrand; H Dombret; M L Scrobohaci; L Degos; P Paul; C Chomienne
Journal:  Leukemia       Date:  1996-01       Impact factor: 11.528

7.  Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.

Authors:  Pau Montesinos; Juan M Bergua; Edo Vellenga; Chelo Rayón; Ricardo Parody; Javier de la Serna; Angel León; Jordi Esteve; Gustavo Milone; Guillermo Debén; Concha Rivas; Marcos González; Mar Tormo; Joaquín Díaz-Mediavilla; Jose D González; Silvia Negri; Elena Amutio; Salut Brunet; Bob Lowenberg; Miguel A Sanz
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

8.  Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.

Authors:  S De Botton; H Dombret; M Sanz; J S Miguel; D Caillot; R Zittoun; M Gardembas; A Stamatoulas; E Condé; A Guerci; C Gardin; K Geiser; D C Makhoul; O Reman; J de la Serna; F Lefrere; C Chomienne; C Chastang; L Degos; P Fenaux
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

9.  All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4.

Authors:  M Marchetti; A Falanga; S Giovanelli; E Oldani; T Barbui
Journal:  Br J Haematol       Date:  1996-05       Impact factor: 6.998

10.  Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.

Authors:  C Dubois; M H Schlageter; A de Gentile; N Balitrand; M E Toubert; I Krawice; P Fenaux; S Castaigne; Y Najean; L Degos
Journal:  Leukemia       Date:  1994-10       Impact factor: 11.528
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.